Knaneh, J.; Hodak, E.; Fedida-Metula, S.; Edri, A.; Eren, R.; Yoffe, Y.; Amitay-Laish, I.; Prag Naveh, H.; Lubin, I.; Porgador, A.;
et al. mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy. Cancers 2023, 15, 4421.
https://doi.org/10.3390/cancers15174421
AMA Style
Knaneh J, Hodak E, Fedida-Metula S, Edri A, Eren R, Yoffe Y, Amitay-Laish I, Prag Naveh H, Lubin I, Porgador A,
et al. mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy. Cancers. 2023; 15(17):4421.
https://doi.org/10.3390/cancers15174421
Chicago/Turabian Style
Knaneh, Jamal, Emmilia Hodak, Shlomit Fedida-Metula, Avishay Edri, Rachel Eren, Yael Yoffe, Iris Amitay-Laish, Hadas Prag Naveh, Ido Lubin, Angel Porgador,
and et al. 2023. "mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy" Cancers 15, no. 17: 4421.
https://doi.org/10.3390/cancers15174421
APA Style
Knaneh, J., Hodak, E., Fedida-Metula, S., Edri, A., Eren, R., Yoffe, Y., Amitay-Laish, I., Prag Naveh, H., Lubin, I., Porgador, A., & Moyal, L.
(2023). mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy. Cancers, 15(17), 4421.
https://doi.org/10.3390/cancers15174421